Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Overview

杭州启明医疗器械股份有限公司是中国领先的经导管心脏瓣膜医疗器械企业。公司自主研发的产品VenusA-Valve是首个获国家药品监督管理局 (「NMPA」)批准及在中国进行商业化的经导管主动脉瓣置换术(「TAVR」)产品。作为中国经导管心脏瓣膜行业的先锋,公司拥有先发优势。公司的使命是成为开发及供应结构性心脏病的经导管解决方案的开发及商业化的全球领导者。.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors3
HongShanVia a fund
125 portfolio companies: Zhipin, EcoFlow, Canva and 122 more
Cowin CapitalVia a fund
215 portfolio companies: 闪捷信息, 金多多, 三顺纳米 and 212 more
383 portfolio companies: Zhipu AI, zuzuche, Zuoshouyisheng and 380 more

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Hangzhou China
HQ